baber/WOPTO huggingface dataset:
Patent NZ-536605-A (NZ)
Title: C-aryl glucoside inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2)
Inventor: ELLSWORTH BRUCE
IPC: A61P13/12
Filed: 2003-05-15
Abstract: An C-aryl glucoside inhibitors of sodium dependent glucose transporters which is found in the intestine and kidney (SGLT2) is disclosed, wherein the C-aryl glucoside compound is represented by formula (I). These compounds are used in the manufacture of a medicament for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the compound alone or in combination with another antidiabetic agent or other therapeutic agent.
Patent NZ-537886-A (NZ)
Title: Pyrimidine derivatives and their use as CB2 modulators
Inventor: EATHERTON ANDREW JOHN
IPC: C07D401/06
Filed: 2003-08-19
Abstract: Disclosed is the pyrimidine derivative 2-(2,4-Dichlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid (tetrahydropyran-4-ylmethyl)-amide. This compound is suitable for the treatment or prevention of conditions such as immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis or osteoporosis and in the treatment of conditions which are mediated by the activity of cannabinoid 2 receptors.
Patent NZ-539854-A (NZ)
Title: Device for dispensing as an unclosed loop, typically as a bracelet with end axes orthogonal to each other
Inventor: SNELLING PAUL DOUGLAS
IPC: B67D7/84
Filed: 2005-05-05
Abstract: A dispensing device can be worn around a wearers wrist or other portion of the wearer, to dispense products, for example cosmetics.
Patent NZ-539999-A (NZ)
Title: A polynucleotide vaccine comprising a polynucleotide sequence that encodes the HCV core protein and a polynucleotide that encodes at least one other HCV protein
Inventor: BRETT SARA
IPC: A61P31/14
Filed: 2003-11-13
Abstract: Disclosed is a composition useful in the treatment and prevention of Hepatitis C virus (HCV) infections and the symptoms and diseases associated therewith. In particular, DNA vaccines that encode the HCV Core protein and a polynucleotide sequence that encodes at least one other HCV protein, wherein the vaccine causes expression of the proteins within the same cell and the sequence of the polynucleotide sequence encoding the core protein has been mutated or positioned relative to the polynucleotide sequence encoding the at least one other HCV protein such that the negative effect of expression of the Core protein upon the expression of the said at least one other HCV protein is reduced.
Patent NZ-542178-A (NZ)
Title: Improvements in/or relating to an internet-based information service
Inventor: ROBINSON ANDREW FRANKLIN
Filed: 2005-09-02
Abstract: An information service is disclosed. The information service comprises a network where material on the network is provided by an entity. The network provides, or is linked to, a request for information means, for submission of a request by a submitter to the entity. A means to optionally provide an inducement to likely submitters or selected subgroup or subgroups of likely submitters to submit a query is also provided.
Patent NZ-542801-A (NZ)
Title: Method and apparatus for removing dust from a workpiece
Inventor: WADGE BRIAN
IPC: B23Q11/00
Filed: 2004-03-11
Abstract: A jigsaw having a housing 4,6 and a support shoe 38 pivotable relative to the housing is disclosed. A bridge member 42 is mounted to the support shoe 38 and is connected to a connector piece 44 to define a conduit for transporting air from a duct in the housing, connected to a fan for cooling a motor in the housing, to a location at which a jigsaw blade of the jigsaw cuts through a workpiece. Actuation of a trigger 10 on the housing supplies power to a motor in the housing, which causes reciprocating motion of the jigsaw blade, and causes the fan in the housing to expel air through bridge member 42. Air is directed from bridge member 42 onto the jigsaw blade in a direction transverse to a line of cutting action of the jigsaw. This enables 10 the outlet of bridge member 42 to be located very close to the jigsaw blade without obscuring the user's view of the blade, and blows dust away from the line to be cut by the jigsaw 2.
Patent NZ-544200-A (NZ)
Title: Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Inventor: JONES ROBERT M
IPC: C07D215/233
Filed: 2004-07-13
Abstract: Disclosed are compounds of formula (I), wherein M and J are N, V is a bond, at least two of W, X and Y are N and the other is N or C optionally substituted; T, U and Z are C, T is optionally substituted, Q is O, S, S(O) or S(O)2, A and B are optionally substituted C1-3 alkylene, D is C or N substituted by R2, and the remaining substituents are as defined in the specification. The compounds are useful in the prophylaxis or treatment of metabolic disorders and complications thereof, such as diabetes and obesity.
Patent NZ-546758-A (NZ)
Title: Telephone or data socket and plug casing with rotating shutter
Inventor: SIMS DAVID JOHN
Filed: 2006-04-21
Abstract: An assembly to hold a telecommunication or data socket 3 includes a casing that encloses and holds at least the front portion of the socket, the casing having a front plug aperture 15 to receive the plug 7 that plugs into the socket, and a shutter 5 with a front face that can be opened to allow entry of the plug into the aperture or closed so that the front face blocks the plug aperture. The shutter is a rotating shutter that rotates about an axis of rotation located within the casing backward of the aperture and remote from the front face of the shutter. Patent of Addtion filed as 573984
Patent NZ-547818-A (NZ)
Title: Blade for a cutting tool
Inventor: DAVIES CHRISTOPHER
Filed: 2003-07-25
Abstract: A blade 7 for a cutting tool, has a tapered cutting portion 7a having opposed tapering cutting edges 7f,7g terminating at an apex 61 of the blade. The blade is configured such that: (i) at least one of the tapering cutting edges 7f,7g has a cutting edge bevel defining an angle of substantially 40 degrees or less; and/or (ii) both opposed tapering cutting edges 7f,7g have a cutting edge bevel; and/or (iii) at least one of the tapering cutting edges 7f,7g has a cutting edge bevel on upper and lower portions of the blade defining a double bevel. The blade 7 may be flat or may be bent to a right angle such that the fixing portion 7b and cutting portion 7a are perpendicular to each other.
Patent NZ-560917-A (NZ)
Title: Cyclopentapyridine and tetrahydroquinoline derivatives
Inventor: CHEN HOU
IPC: A61K31/435
Filed: 2006-03-21
Abstract: Disclosed are substituted cyclopentapyridine / tetrahydroquinoline piperazine derivatives as represented by the general formula (I) which are useful for the treatment of a 5-HT2C receptor-mediated diseases, wherein m is 1 or 2; n is 0 or 1; L is -CH2 or -CH(alkyl); R2 is hydrogen or methyl; R3 is selected from the group consisting of H, CI, Br, F, CH3 and CN; R1 is an optionally substituted phenyl or heteroaryl ring; and wherein the remaining substituents are as defined herein. Also disclosed is the use of compounds as defined above, for the manufacture of a medicament for the treatment of diseases such as eating disorders, obesity, diabetes, depression, bipolar disorders, psychoses, schizophrenia, behavioral addictions, addictive disorders, impulsivity, alcoholism, tobacco abuse, premenstrual syndrome, migraine, panic disorder, anxiety, post-traumatic syndrome, dementia etc..
Patent NZ-561361-A (NZ)
Title: GIP hybrid polypeptides with at least two hormonal activities
Inventor: LEVY ODILE ESTHER
IPC: A61P3/00
Filed: 2006-02-10
Abstract: Disclosed is a GIP hybrid polypeptide exhibiting at least two hormonal activities, said hybrid polypeptide comprising a first bio-active peptide hormone module covalently linked to at least one additional bio-active peptide hormone module; wherein: the bio-active peptide hormone modules are independently selected from the group consisting of: component peptide hormones, fragments of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, and fragments of analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones; the component peptide hormone of the first bio-active peptide hormone module is a GIP; the component peptide hormone of the at least one additional bio-active peptide hormone modules are independently selected from the group consisting of: amylin, adrenomedullin (ADM), calcitonin (CT), calcitonin gene related peptide (CGRP), intermedin, cholecystokinin ("CCK"), leptin, peptide YY (PYY), glucagon-like peptideÀ1 (GLP-I), glucagon-like peptide 2 (GLP-2), oxyntomodulin (OXM), a natriuretic peptide, a urocortin family peptide, a neuromedin family peptide, exendin-3, and exendin-4; and at least both of the bio-active peptide hormone modules exhibits at least one hormonal activity of its component peptide hormone. The hybrid polypeptides are useful as agents for the treatment and prevention of metabolic diseases and disorders, for example those which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, positive inotropic effects, reduction of catabolic effects, slowing of gastric emptying. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, critical care, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes
Patent NZ-566708-A (NZ)
Title: Association comprising a PPAR ligand and an antioxidant agent and use thereof for treating obesity
Inventor: CASTEILLA LOUIS
IPC: A61K45/06
Filed: 2003-10-10
Abstract: Disclosed is an association, which is rosiglitazone and coenzyme Q10. Also disclosed is the use of the above association in obtaining pharmaceutical compositions intended for the treatment and/or prevention of obesity, specifically obesity that was caused by a therapeutic treatment such as the treatment of type I or II diabetes. (62) Divided Out of 539331
Patent NZ-568857-A (NZ)
Title: End plug for a roll of material, roll of material and retention mechanism in a dispenser
Inventor: LIND MATS
IPC: B65H75/14
Filed: 2006-12-07
Abstract: The disclosure relates to an end plug (5) for a roll of material to be inserted into a retention mechanism (1), the end plug comprising: a receiving portion (60) for being inserted in the roll of material, an end face for contacting the retention mechanism and a bearing member (70) for being inserted into the retention mechanism.; The bearing member comprises a bearing pin (80) comprising a counter surface (82) facing the end face and at least one locking portion (950) for locking the end plug in an end position (250) in the retention mechanism, the locking portion being positioned within a zone (900) defined by a first surface extending towards the end face from an intersection position with the bearing pin, the first surface being inclined with respect to the longitudinal axis of the bearing pin and a second surface (extending towards the end face from the intersection position, the second surface being inclined with respect to the longitudinal axis of the bearing pin by another angle (not shown).
Patent NZ-570191-A (NZ)
Title: Soft-gelatin capsule formulation comprising a keto-prostaglandin compound
Inventor: HASHITERA YUKIKO
IPC: A61K9/48
Filed: 2007-01-23
Abstract: Disclosed is a soft gelatin capsule formulation of a 15-ketoprostaglandin compound, which comprises: a soft gelatin capsule shell comprising gelatin and a sugar alcohol as a plasticizer, and a mixture comprising a 15-keto-prostaglandin compound and a pharmaceutically acceptable vehicle, which is filled in the shell.
Patent NZ-572743-A (NZ)
Title: Hydrogenation process
Inventor: GUDDE NICHOLAS JOHN
IPC: C10G3/00
Filed: 2007-05-18
Abstract: Disclosed is a process for the production of a fuel composition comprising hydrocarbons derived from carboxylic acids and/or carboxylic acid esters, which process comprises the steps of: (a) feeding hydrogen and a first hydrocarbon-containing process stream to a first reactor; (b) maintaining conditions within the first reactor sufficient to produce a first hydrocarbon-containing product stream with a reduced concentration of heteroatom-containing organic compounds and/or olefins compared to the first hydrocarbon-containing process stream, wherein said heteroatom-containing organic compounds are selected from compounds other than carboxylic acids and esters thereof; (c) removing the first hydrocarbon-containing product stream from the first reactor; wherein the process additionally comprises the steps of: (d) feeding hydrogen, a carboxylic acid and/or carboxylic acid ester, and at least a portion of the first hydrocarbon-containing product stream to a second reactor; (e) maintaining conditions within the second reactor sufficient to convert at least some of the carboxylic acid and/or carboxylic acid ester to one or more hydrocarbons; (f) removing a second hydrocarbon-containing product stream from the second reactor, in which at least a portion of the hydrocarbons are derived from the carboxylic acid and/or carboxylic acid ester.
Patent NZ-575386-A (NZ)
Title: A water supply
Inventor: FLANAGAN MARK BRENDAN
IPC: E03B1/04
Filed: 2009-03-09
Abstract: A water supply circuit 14 comprises a mains water line 11 and an auxiliary water line 12 from a rainwater tank 13, with separate outlets for drinking water 17 and non-drinking water 15, 16 and with a valve 20. The valve 20 is set to preferentially deliver auxiliary water 12 when available from the rainwater tank 13, to the non-drinking water outlet 15, 16. The drinking water outlet 17 is fed from a tapping on the main water line 11 upstream of the valve 20. The arrangement minimises the use of mains water 11 when auxiliary water 12 from the rainwater tank 13 is available.
Patent NZ-580006-A (NZ)
Title: Probiotic bifidobacterium strain 41387
Inventor: MACSHARRY JOHN
IPC: A23L27/60
Filed: 2008-03-28
Abstract: Disclosed is an isolated strain of Bifidobacterium deposited at NCIMB with accessionnumber 41387. Further disclosed are formulations containing said Bifidobacterium strain and uses thereof.
Patent NZ-580977-A (NZ)
Title: A method of stabilizing an aldehyde
Inventor: MARTIN ANTONIETTA PAMELA
IPC: A01N25/22
Filed: 2008-04-04
Abstract: Disclosed is a stable aqueous aldehyde solution that includes: (a) an aldehyde comprising at least one of the following: a monoaldehyde (Diagram 1), a dialdehyde (Diagram 2) and a cyclic aldehyde (Diagram 3) in a 0.001% to 25% m/v concentration: R - CHO Diagram 1 OHC - R1 - CHO Diagram 2 R3 - CHO Diagram 3 and wherein: R = hydrogen, a straight hydrocarbon chain between 1 and 12 carbon atoms in length, or a branched hydrocarbon chain between 4 and 12 carbon atoms in length; -R1= a hydrocarbon chain between 2 and 12 carbon atoms in length; and -R3= a cyclic hydrocarbon having 5 or 6 carbon atoms. (b) a surfactant or detergent chosen from any one of the following: an alcohol ethoxylate surfactant, a nonylphenol surfactant, sodium lauryl ethyl sulphate, sodium lauryl sulphate, a twin chain quaternary ammonium compound and cocopropyldiamide (CPAD); (c) a sufficient amount of a pH modifier to bring the pH of the solution to within a 6.0 to 8.5 range; and (d) a buffer comprising sodium acetate or sodium acetate tri-hydrate and at least one of the following: potassium acetate, lithium acetate, calcium acetate, magnesium acetate, sodium phosphate, sodium tri-phosphate, potassium phosphate, lithium phosphate, zinc perchlorate, zinc sulphate, cupric chlorate and cupric sulphate.
Patent NZ-583062-A (NZ)
Title: An interface device for a wind turbine control system and a method for inputting commands to a wind turbine controller
Inventor: JENSEN MICHAEL
IPC: G08C17/00
Filed: 2008-08-22
Abstract: An interface device for a wind turbine control system, in particular provided for a service or maintenance procedure, where the interface device is connected to a controller of the wind turbine control system for user communication with the controller, is disclosed. The interface device comprises: a controller interface; a processor; a speech recognition unit; a microphone; and an output unit. The controller interface is connected to the controller for sending commands and/or data to and receiving commands and/or data from, the controller. The processor is connected to the controller interface to produce commands and/or data for the controller and to interpret commands and/or data received from the controller and to provide an output a signal representing the interpreted data. The speech recognition unit translates electrical signals representing orally input commands or data into an input command signal or input data signal and which is connected to the processor. The microphone allows an oral command input and/or an oral data input to the interface device. An electrical signal from the microphone is input to the speech recognition unit. The output unit is connected to the processor for receiving commands or data. The processor comprises: a command manager to: produce, upon receipt of an input command signal, a reproduction signal representing the received input command signal in a form which is appropriate to be recognised by the user and a confirmation request signal, to deliver the reproduction signal and the confirmation request signal to the output unit, and to further process the received input command signal only upon receipt of a confirmation by the user. The interface device provides an inactive state, an idle state, a watchdog state representing a dead man button function, an error state, an operator information state and a command state.
Patent NZ-586105-A (NZ)
Title: Dispenser and method for entraining powder in an airflow by creating eddies over recessed powder containing cavity within flat upstrean and downstream surfaces
Inventor: BRIANT JOHN
IPC: A61M15/00
Filed: 2008-12-18
Abstract: The disclosure relates to a method for entraining in an airflow a medicament powder contained in a cavity having a cavity opening. Large airflow vortices are provided, for instance, by means of an obstacle in a flow passage. The airflow with large vortices is arranged to by-pass the cavity opening, thereby generating an eddy in the cavity which contributes to entraining the powder in said airflow. The disclosure also relates to a medical dispenser, for instance an inhaler, in which said method may be performed.
Patent NZ-587043-A (NZ)
Title: Production of canola protein isolate
Inventor: GOSNELL BRANDY
IPC: A23J1/14
Filed: 2006-06-30
Abstract: Disclosed is a method for the preparation of a canola protein isolate consisting predominantly of the 2S canola protein, which includes: extracting canola oil seed meal with water to preferentially extract 7S and 12S canola proteins and soluble impurities in preference to the 2S protein, to form a first canola protein extract solution, separating the first canola protein extract solution from the residual oil seed meal, extracting the residual oil seed meal with an aqueous salt solution to dissolve 2S, 7S and 12S proteins from the residual oil seed meal to form a second canola protein extract solution, and recovering a canola protein isolate from the second canola protein extract solution having a protein content of at least 90 wt% (N x 6.25) and consisting predominantly of 2S canola protein. (62) Divided Out of 565495
Patent NZ-587771-A (NZ)
Title: Novel benzoxazine benzimidazole derivatives, pharmaceutical composition comprising same, and a use thereof
Inventor: KIM JI DUCK
IPC: C07D413/14
Filed: 2009-04-16
Abstract: Disclosed is a benzoxazine derivative of formula (1), or a salt, hydrate, solvate, or stereoisomer thereof, where the substituents and variables are as defined in the specification. Also disclosed is the use of the above compound to treat diseases associated with antagonistic activity of vanilloid receptor, such as acute pain, chronic pain, neuropathic pain, postoperative pain, migraines, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neurological illness, neurodermatitis, stroke, bladder hypersensitivity, obesity, irritable bowel syndrome, cough, asthma, Chronic Obstructive Pulmonary Disease, glaucoma, burns, psoriasis, itching, vomiting, irritation of the skin, eyes, or mucous membranes, reflux esophagitis, gastricduodenal ulcers, and inflammatory diseases.
Patent NZ-594646-A (NZ)
Title: Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
Inventor: VIRNO MICHELE
IPC: A61K9/06
Filed: 2010-02-02
Abstract: 594646 Disclosed herein is a pharmaceutical formulation comprising ketoprofen; at least one polyoxyalkylene ester of a hydroxy fatty acid obtained from the esterification of a hydroxy fatty acid having from 8 to 30 carbon atoms with a polyoxyalkylene having a molecular weight ranging from 200 to 6,000; at least one hydroxy substituted organic compound independently selected from the list consisting of an alcohol, a polyol and mixtures of these, wherein, the or each said alcohol is independently selected from the list consisting of ethanol, 1-propanol, and 2-propanol; and ii. the or each said polyol is independently selected from the list consisting of glycerol, propylene glycol, and 1,3-butylene glycol; and (iv) water.
Patent NZ-597077-A (NZ)
Title: Metal-coated steel strip
Inventor: SMITH ROSS MCDOWALL
IPC: C23C2/26
Filed: 2010-05-27
Abstract: NZ 597077 The disclosure relates to a method of forming a metal coated strip, such as a steel strip, which comprises: (a) passing the strip through a hot dip coating bath that contains Al, Zn, Si, and Mg and optionally other elements and forming a molten Al-Zn-Si-Mg alloy coating on the strip, (b) cooling the coated strip, preferably at a rate of at least 600ºC/sec, to solidify the molten Al-Zn-Si-Mg alloy on the strip and form a solidified coating having a microstructure that comprises alpha-Al phase dendrites, Zn-rich phases in interdendritic regions, and Mg2Si phase particles in interdendritic regions; and (c) heat treating the coated strip at a temperature of at least 300°C and for a time, preferably between 15 to 30 minutes, to form an Al-Zn phase solid solution from the as-cast microstructure of alpha-Al phase dendrites and the Zn-rich interdendritic phases and to facilitate globularisation of the Mg2Si phase particles that are dispersed in the coating; and (d) cooling the heat treated strip at a rate that minimises growth of Mg2Si phase particles and at least substantially retains the globular Mg2Si phase particles that form in the heat treatment step (c). Also disclosed is a strip, such as a steel strip, that has a coating of an Al-Zn-Si-Mg alloy on the strip that has a microstructure that comprises a solid solution of an Al-Zn phase and a dispersion of particles of Mg2Si phase in the coating, with the Mg2Si particles having: (a) a particle size of ≤ 2 microns, and (b) a globular shape.